Andrew Ko, MD, FASCO
Professor of Clinical Medicine; Associate Division Chief, Oncology, Division of Hematology/Oncology, UCSF
My primary clinical and research interests focus on gastrointestinal malignancies, particularly pancreatic cancer and upper-GI malignancies, where I have been focused on the evaluation of new therapeutic agents (ranging from novel cytotoxics to molecular targeted agents to immunotherapies) through the development, leading, and conduct of clinical trials supported by industry collaborators, the National Cancer Institute/CTEP, and various consortia/foundations. This work has included efforts to identify individual patient/tumor characteristics that influence prognosis and response to specific therapies, including both tissue- and blood-based biomarkers.
At a national level I am also responsible for developing and shepherding new trial concepts in pancreatic cancer through roles in the NCI's Pancreatic Cancer Task Force (of which I currently serve as chair) and the Alliance for Clinical Trials in Oncology national cooperative group. I have also served on the scientific program committee, grants committee, and specialty editorial board for the American Society of Clinical Oncology (ASCO); sit on the editorial board for multiple peer-reviewed oncology journals, including assuming the role as Associate Editor for GI Cancers for the Journal of Clinical Oncology beginning in 2016; and am a member of the NCCN Pancreatic Cancer guidelines committee.
Leadership and administrative responsibilities at my institution have included leading our site committee for gastrointestinal cancer-specific clinical trial development at the UCSF Comprehensive Cancer Center; chairing the scientific Protocol Review Committee; and, from Sept 2018 – June 2022, serving as (interim) Chief in our Division of Hematology/Oncology.
Brown University, Providence, RI, Sc.B., 1991, Applied Mathematics/Biology
Johns Hopkins School of Medicine, Baltimore, MD, M.D., 1995, Medicine
Board certified, Internal Medicine, 1998
Board certified, Medical Oncology, 2002